Heart Rate Monitoring Clinical Trial
Official title:
Enhanced Heart Rate Monitoring of Newborns After Birth and During Resuscitation
In a multicenter randomized controlled trial the investigators will evaluate the efficacy of the novel heart rate meter NeoBeat on ventilation performance and short-term outcomes compared to standard care in newborns in need of positive pressure ventilation to initiate spontaneous breathing after birth.
Heart rate assessment immediately after birth in newborn infants is the most important
clinical indicator to evaluate the status of a newborn, and critical to the correct guidance
of resuscitation efforts.
One of the knowledge gaps identified by the International Liason Committee on Resuscitation
(ILCOR) is how best to assess ventilation during newborn resuscitation, and improved
technology for rapid application of ECG.
Laerdal Medical has developed a novel heart rate meter, NeoBeat, implementing ECG
dry-electrodes in a snug-fit abdomen-shaped buckle for for rapid application on the newborn.
In a multicenter randomized controlled trial the investigators will study the efficacy of
NeoBeat on ventilation performance and short-term outcomes compared to standard care in
newborns in need of positive pressure ventilation to initiate spontaneous respiration after
birth.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06076057 -
Vital Signs Monitoring of Emergency Responders in Different States
|
||
| Completed |
NCT02527408 -
Wearable Technology for Hospital Inpatients
|
N/A |